English
With a need of up to 193 million tests per month1 to mitigate COVID-19 and current testing capacity is ~21 million tests per month according to the COVID Tracking Project2, expanded mass ability is crucial to aid in reopening public spaces with confidence.
Dr. Chidinma Chima-Melton, MD, MBA, FCCP, UCLA Regional Medical Director of Pulmonary, will take us on a journey through the latest types of COVID-19 testing modalities and provides an insightful discussion on diagnostic approaches in patient use cases from the eyes of a pulmonary and ,critical care clinician and administrator.
UCLA Regional Medical Director of Pulmonary
Assistant Clinical Professor of Medicine, Regional Medical Director of Pulmonary & Medical Director of Quality for Specialty Care at David Geffen School of Medicine at UCLA
Dr. Chidinma Chima-Melton received her medical degree from Stony Brook University School of Medicine, New York. She completed her training in ,Internal Medicine at Yale University in New Haven, Connecticut.
Following her fellowship, Dr. Chima-Melton joined UCLA and is currently a board certified pulmonologist with an interest in Interstitial Lung Disease (ILD), Occupational and Environmental lung diseases.
Dr. Chidinma Chima-Melton, MD, MBA, FCCP, UCLA Regional Medical Director of Pulmonary, will take us on a journey through the latest types of COVID-19 testing modalities and provides an insightful discussion on diagnostic approaches in patient use cases from the eyes of a pulmonary and ,critical care clinician and administrator.
What you will learn
- Diagnostic approach to SARS-COV-2 testing
- Various types of SARS-COV-2 testing modalities: Diagnostic (Viral) testing: Molecular and Antigen Serological (Antibody) testing: IgG, IgM
- A real-world case-based discussion on role and consideration of clinical testing for SARS-COV-2
About the speaker
Dr. Chidinma Chima-Melton, MD, MBA, FCCPUCLA Regional Medical Director of Pulmonary
Assistant Clinical Professor of Medicine, Regional Medical Director of Pulmonary & Medical Director of Quality for Specialty Care at David Geffen School of Medicine at UCLA
Dr. Chidinma Chima-Melton received her medical degree from Stony Brook University School of Medicine, New York. She completed her training in ,Internal Medicine at Yale University in New Haven, Connecticut.
Following her fellowship, Dr. Chima-Melton joined UCLA and is currently a board certified pulmonologist with an interest in Interstitial Lung Disease (ILD), Occupational and Environmental lung diseases.
